Literature DB >> 30696317

Botulinum Toxin A Injection for Treatment of Chronic Skin Ulcer: A Case Series and Literature Review.

Jiaojiao Zhong1, Yu Lan1, Shuying Fu1, Jing Zhang1, Sha Lu1, Yunan He1, Jun-Min Zhang1.   

Abstract

Chronic skin ulcer (CSU) often combines with a variety of refractory factors that respond poorly to routine treatments. Botulinum toxin A (BTX-A) can be injected subcutaneously to improve the local blood supply, to reduce pain, and to promote wound healing. At present, few reports have mentioned BTX-A injection for chronic skin ulcer treatment. We observed the effect of four cases that used BTX-A to treat CSU and provided a brief review of the literature. Four cases of CSUs with 4 different causes were treated with BTX-A injection (4 U/cm2). The specific operation is as follows: local, multipoint, cyclic, equidistant, and subcutaneous injections with a depth of 6 to 8 mm. The ulcer area was significantly reduced. Subsequently, the ulcer healed within 20 to 48 days. Botulinum toxin A is recommended as an important treatment for chronic skin ulcer that can improve healing of skin ulcers with various etiologies.

Entities:  

Keywords:  botulinum toxin A; case report; chronic skin ulcer; treatment

Mesh:

Substances:

Year:  2019        PMID: 30696317     DOI: 10.1177/1534734618816589

Source DB:  PubMed          Journal:  Int J Low Extrem Wounds        ISSN: 1534-7346            Impact factor:   2.057


  2 in total

Review 1.  Botulinum Toxin Type A for the Treatment of Skin Ulcers: A Review Article.

Authors:  Waranaree Winayanuwattikun; Vasanop Vachiramon
Journal:  Toxins (Basel)       Date:  2022-06-14       Impact factor: 5.075

2.  Botulinum toxin-A: A novel treatment for livedoid vasculopathy.

Authors:  Angela M Crotty; Bianca N Eubanks; Vienna G Katana; Kevin T Wright
Journal:  JAAD Case Rep       Date:  2022-08-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.